CTOs on the Move

Ativa Medical

www.ativamed.com

 
Ativa Medical Corp. is a privately held, emerging growth medical diagnostic company developing and commercializing novel point-of-care diagnostic technologies. Ativa Medical is a developer of the world’s first diagnostic micro lab to help clinicians make immediate treatment decisions This technology will enable health care professionals to perform critical hematology and blood chemistry tests on-site and get accurate results within about 5 minutes. For more information, visit our website.
  • Number of Employees: 5K-10K
  • Annual Revenue: $0-1 Million
  • www.ativamed.com
  • 1000 Westgate Dr. Suite 100
    St. Paul, MN USA 55114
  • Phone: 612.293.3993

Executives

Name Title Contact Details

Similar Companies

BioAssay Systems

BioAssay Systems is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Resonance Research

Resonance Research is a Billerica, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BIOCARDIA

BIOCARDIA is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Augmedics

Augmedics develops xvision™ – an Augmented-Reality Head-Mounted Display for spine surgery. xvision allows surgeons to see the patient`s anatomy through skin and tissue, as if they had "X-Ray Vision"​. Based on Augmedics` patented technology, the xvision system can project the patient`s anatomy, in real time, directly onto the surgeon`s retina, with surgical precision and outstanding depth perception. xvision will increase safety in surgery, reduce x-ray radiation, and facilitate minimally invasive procedures.

MY01

MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.